ANDA 84802, held by Lederle. Chlorpromazine Hydrochloride.
As of Nov 16, 2026, ANDA 84802 (Chlorpromazine Hydrochloride), held by Lederle, was not approved, with 1 approved supplement and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlorpromazine Hydrochloride200MG ยท tablet;oral | Chlorpromazine Hydrochloride | Discontinued |
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 24, 1982 | Supplement 9Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters